Dissertation / PhD Thesis/Book PreJuSER-29120

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Glukoselimitierung als Strategie zur Steigerung der Produktion von MUC1 und anderen rekombinanten Glykoproteinen mit CHO-Zellen



2004
Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag Jülich

Jülich : Forschungszentrum Jülich GmbH Zentralbibliothek, Verlag, Berichte des Forschungszentrums Jülich 4112, F, 135, XIII S. () = Bonn, Univ., Diss., 2003

Please use a persistent id in citations:

Report No.: Juel-4112

Abstract: Many researchers are interested in glucose-limited perfusion culture in order to improve cellular metabolism towards more efficient substrate consumption and reduced production of cytotoxic metabolites (e.g. lactate). This work presents the development of a highly reproducible glucose-limited perfusion process using a recombinant CHO cell line producing human MUC-1 glycoprotein (currently under evaluation for immunotherapy of breast cancer) in a standard stirred vessel bioreactor with cell retention by spin filter using serum-free medium. The strategy is easy to perform and does not need any online glucose or other invasive measurement making the process highly stable against disturbances. Using this strategy, glucose consumption rate decreases, glucose concentration in the bioreactor drops and remains below detectable levels and the cells do not longer produce any lactate, while cell specific productivity and space time yield increase 5-fold and 4-fold respectively (250mg/L/day). Viable cell density remains very high at 1-2*E7 cells/mL. Process time can easily be extended to more than 1000h. The glycosylation pattern ofthe product is unaffected, as shown by detailed glycoanalysis. Based on preliminary results from substrate bilancing and 13C-lactate feeding experiments which prove a switch in metabolism towards an increased TCA-cycle activity and which indicate gluconeogenesis, a metabolic model has been set up and is discussed in detail. Finally this process strategy has been transferred successfully to a second recombinant CHO cell line secreting another mucin.


Note: Record converted from VDB: 12.11.2012
Note: Bonn, Univ., Diss., 2003

Contributing Institute(s):
  1. Biotechnologie 2 (IBT-2)
Research Program(s):
  1. Biotechnologie (L02)

Appears in the scientific report 2004
Database coverage:
OpenAccess
Click to display QR Code for this record

The record appears in these collections:
Document types > Theses > Ph.D. Theses
Institute Collections > IBG > IBG-1
Workflow collections > Public records
Publications database
Open Access

 Record created 2012-11-13, last modified 2020-06-10


OpenAccess:
Download fulltext PDF
External link:
Download fulltextFulltext by OpenAccess repository
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)